Drawing for CLOSE UP

USPTO serial 72226846

CLOSE UP

Reviewed by CopyMark Law Group

Reg. 0813333Status 900
Filing date
Status date
Registration date
Aug 23, 1966
Examiner
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLOSE UP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LYNNE DARCY

KENNETH C LEONARD UNILEVER UNITED STATES INCUNILEVER LAW DEPT33 BENEDICT PLGREENWICH, CT 06830

Goods and services

ClassDescriptionStatusFirst use
018ORAL ANTISEPTIC FOR INHIBITION OF BACTERIA IN THE MOUTHEXPIREDNov 24, 1963

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 26, 2007CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Apr 28, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 28, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 11, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 27, 2005MAILPAPER RECEIVED
Oct 5, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 23, 1986REN1REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)
Jul 28, 19869.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8

Frequently asked questions

Related guidance